Depomed Says It Was Cheated Out Of Orphan Drug Exclusivity

Depomed Says It Was Cheated Out Of Orphan Drug Exclusivity

Depomed Inc. urged a Washington federal judge Friday to force the U.S. Food and Drug Administration to give the company seven years of drug exclusivity for its pain drug Gralise, claiming the agency went beyond its authority and added new limitations ...read more

  • Tags: